Abstract
Bioconjugation methods are critical for the stable conjugation of metallic and nonmetallic radionuclides to biomolecular targeting vectors. In contrast to the radiosynthesis of most small molecule tracers, the creation of biomolecular imaging agents typically employs biomolecules in their native form, eschews protective groups, and generally involves no more than one or two steps. Because the majority of biomolecules contain not only different functional groups but also multiple copies thereof at different positions, particular attention has to be paid to the chemoselectivity and site-specificity of bioconjugation reactions. In addition, the sensitivity of many biomolecules frequently means that mild aqueous reaction conditions must be used, a requirement which imposes further restrictions on radiolabeling protocols. Taken together, these factors combine to make the controlled functionalization of biomolecules a non-trivial task. In this chapter, we discuss the various bioconjugation methods that have been harnessed for the development of biomolecular radiopharmaceuticals. Several classical approaches based on bifunctional reactive probes will be discussed as well as a number of more recently developed strategies employing enzymes and biorthogonal chemistry. The strengths and limitations of each approach will be addressed, and examples of the application of each strategy to different classes of biomolecules will be provided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hermanson GT, editor. Bioconjugate techniques. 3rd ed. Boston: Academic Press; 2013.
Algar WR, Dawson P, Medintz IL, editors. Chemoselective and bioorthogonal ligation reactions: concepts and applications. Weinheim: Wiley-VCH Verlag; 2017.
Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, et al. Consensus nomenclature rules for radiopharmaceutical chemistry – setting the record straight. Nucl Med Biol. 2017;55:v–xi.
Sletten EM, Bertozzi CR. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew Chem Int Ed Eng. 2009;48(38):6974–98.
Rodwell VW, Bender D, Botham KM, Kennelly PJ, Weil PA, editors. Harper’s illustrated biochemistry. 30th ed. New York: McGraw-Hill Education; 2015.
Ermert J, Coenen HH. Methods for 11C- and 18F-labelling of amino acids and derivatives for positron emission tomography imaging. J Label Compd Radiopharm. 2013;56(3–4):225–36.
Koniev O, Wagner A. Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation. Chem Soc Rev. 2015;44(15):5495–51.
deGruyter JN, Malins LR, Baran PS. Residue-specific peptide modification: a chemist's guide. Biochemistry. 2017;56(30):3863–73.
Adumeau P, Sharma SK, Brent C, Zeglis BM. Site-specifically labeled immunoconjugates for molecular imaging–part 1: cysteine residues and glycans. Mol Imaging Biol. 2016;18(1):1–17.
Charron CL, Hickey JL, Nsiama TK, Cruickshank DR, Turnbull WL, Luyt LG. Molecular imaging probes derived from natural peptides. Nat Prod Rep. 2016;33(6):761–800.
Bernhard C, Moreau M, Lhenry D, Goze C, Boschetti F, Rousselin Y, et al. DOTAGA-anhydride: a valuable building block for the preparation of DOTA-like chelating agents. Chemistry. 2012;18(25):7834–41.
Hnatowich D, Layne W, Childs R, Lanteigne D, Davis M, Griffin T, et al. Radioactive labeling of antibody: a simple and efficient method. Science. 1983;220(4597):613–5.
van der Born D, Pees A, Poot AJ, Orru RVA, Windhorst AD, Vugts DJ. Fluorine-18 labelled building blocks for PET tracer synthesis. Chem Soc Rev. 2017;46(15):4709–73.
Chin J, Vesnaver M, Bernard-Gauthier V, Saucke-Lacelle E, Wängler B, Wängler C, et al. Direct one-step labeling of cysteine residues on peptides with [11C]methyl triflate for the synthesis of PET radiopharmaceuticals. Amino Acids. 2013;45(5):1097–108.
Jeon J, Shen B, Xiong L, Miao Z, Lee KH, Rao J, et al. Efficient method for site-specific 18F-labeling of biomolecules using the rapid condensation reaction between 2-cyanobenzothiazole and cysteine. Bioconjug Chem. 2012;23(9):1902–8.
Leier SRS, Wuest F. Radiometal-containing arene diazonium salts for chemoselective bioconjugation of tyrosine residues. J Label Compd Radiopharm. 2017;60(Suppl 1):S94.
Moradi SV, Hussein WM, Varamini P, Simerska P, Toth I. Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides. Chem Sci. 2016;7(4):2492–500.
Rodwell JD, Alvarez VL, Lee C, Lopes AD, Goers JW, King HD, et al. Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations. Proc Natl Acad Sci U S A. 1986;83(8):2632–6.
Jeong JM, Lee J, Paik CH, Kim D-K, Lee DS, Chung J-K, et al. Site-specific99mTc-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain. Arch Pharm Res. 2004;27(9):961–7.
Kurth M, Pelegrin A, Rose K, Offord RE, Pochon S, Mach JP, et al. Site-specific conjugation of a radioiodinated phenethylamine derivative to a monoclonal antibody results in increased radioactivity localization in tumor. J Med Chem. 1993;36(9):1255–61.
Namavari M, Cheng Z, Zhang R, De A, Levi J, Hoerner JK, et al. A novel method for direct site-specific radiolabeling of peptides using [18F]FDG. Bioconjug Chem. 2009;20(3):432–6.
Maschauer S, Prante O. A series of 2-O-trifluoromethylsulfonyl-D-mannopyranosides as precursors for concomitant 18F-labeling and glycosylation by click chemistry. Carbohydr Res. 2009;344(6):753–61.
Younes C, Boisgard R, Tavitian B. Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives. Curr Pharm Des. 2002;8(16):1451–66.
Bogdanov A, Licha K, editors. Molecular Imaging, an essential tool in preclinical research, diagnostic imaging and therapy. Berlin: Springer-Verlag; 2005.
Alauddin MM. Nucleoside-based probes for imaging tumor proliferation using positron emission tomography. J Label Compd Radiopharm. 2013;56(3–4):237–43.
Gijs M, Aerts A, Impens N, Baatout S, Luxen A. Aptamers as radiopharmaceuticals for nuclear imaging and therapy. Nucl Med Biol. 2016;43(4):253–71.
Dolle F, Hinnen F, Vaufrey F, Tavitian B, Crouzel C. A general method for labeling oligodeoxynucleotides with 18F for in vivo PET imaging. J Label Compd Radiopharm. 1997;39(4):319–30.
Gijs M, Dammicco S, Warnier C, Aerts A, Impens NR, D'Huyvetter M, et al. Gallium-68-labelled NOTA-oligonucleotides: an optimized method for their preparation. J Label Compd Radiopharm. 2016;59(2):63–71.
Cevc G, editor. Phospholipid handbook. New York: Marcel Dekker; 1993.
Poulsen RH, Rasmussen JT, Bøtker HE, Waehrens LS, Falborg L, Heegaard CW, et al. Imaging the myocardium at risk with 99mTc-lactadherin administered after reperfusion in a porcine model. Nucl Med Biol. 2014;41(1):114–9.
Schwarzenböck S, Souvatzoglou M, Krause BJ. Choline PET and PET/CT in primary diagnosis and staging of prostate cancer. Theranostics. 2012;2(3):318–30.
Zeng H, Zhang T, Song F, Wu X. Technetium-99m labeled fatty acid analogues for SPECT imaging in heart and liver. Med Chem. 2014;4:481–6.
de Barros AB, Tsourkas A, Saboury B, Cardoso VN, Alavi A. Emerging role of radiolabeled nanoparticles as an effective diagnostic technique. EJNMMI Res. 2012;2(1):39.
Lamichhane N, Dewkar GK, Sundaresan G, Mahon RN, Zweit J. [18F]-fluorinated carboplatin and [111In]-liposome for image-guided drug delivery. Int J Mol Sci. 2017;18:1079.
Seo JW, Mahakian LM, Kheirolomoom A, Zhang H, Meares CF, Ferdani R, et al. Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects. Bioconjug Chem. 2010;21(7):1206–15.
Seo JW, Mahakian LM, Tam S, Qin S, Ingham ES, Meares CF, et al. The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model. Nucl Med Biol. 2015;42(2):155–63.
Onega M, Winkler M, O'Hagan D. Fluorinase: a tool for the synthesis of 18F-labeled sugars and nucleosides for PET. Future Med Chem. 2009;1(5):865–73.
Massa S, Vikani N, Betti C, Ballet S, Vanderhaegen S, Steyaert J, et al. Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities. Contrast Media Mol Imaging. 2016;11(5):328–39.
Paterson BM, Alt K, Jeffery CM, Price RI, Jagdale S, Rigby S, et al. Enzyme-mediated site-specific bioconjugation of metal complexes to proteins: sortase-mediated coupling of copper-64 to a single-chain antibody. Angew Chem Int Ed Eng. 2014;53(24):6115–9.
Jeger S, Zimmermann K, Blanc A, Grunberg J, Honer M, Hunziker P, et al. Site-specific and stoichiometric modification of antibodies by bacterial transglutaminase. Angew Chem Int Ed Eng. 2010;49(51):9995–7.
Zeglis BM, Davis CB, Aggeler R, Kang HC, Chen A, Agnew BJ, et al. Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry. Bioconjug Chem. 2013;24(6):1057–67.
Adumeau P, Sharma SK, Brent C, Zeglis BM. Site-specifically labeled immunoconjugates for molecular imaging–part 2: peptide tags and unnatural amino acids. Mol Imaging Biol. 2016;18(2):153–65.
Waibel R, Alberto R, Willuda J, Finnern R, Schibli R, Stichelberger A, et al. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)–carbonyl complex. Nat Biotechnol. 1999;17(9):897–901.
Spicer CD, Davis BG. Selective chemical protein modification. Nat Commun. 2014;5:4740.
Noren CJ, Anthonycahill SJ, Griffith MC, Schultz PG. A general-method for site-specific incorporation of unnatural amino-acids into proteins. Science. 1989;244(4901):182–8.
Hallam TJ, Wold E, Wahl A, Smider VV. Antibody conjugates with unnatural amino acids. Mol Pharm. 2015;12(6):1848–62.
Wu Y, Zhu H, Zhang B, Liu F, Chen J, Wang Y, et al. Synthesis of site-specific radiolabeled antibodies for radioimmunotherapy via genetic code expansion. Bioconjug Chem. 2016;27(10):2460–8.
Wållberg H, Grafström J, Cheng Q, Lu L, Martinsson Ahlzén HS, et al. HER2-positive tumors imaged within 1 hour using a site-specifically 11C-labeled sel-tagged affibody molecule. J Nucl Med. 2012;53(9):1446–53.
Baldwin AD, Kiick KL. Tunable degradation of maleimide–thiol adducts in reducing environments. Bioconjug Chem. 2011;22(10):1946–53.
Fontaine SD, Reid R, Robinson L, Ashley GW, Santi DV. Long-term stabilization of maleimide–thiol conjugates. Bioconjug Chem. 2015;26(1):145–52.
Lyon RP, Setter JR, Bovee TD, Doronina SO, Hunter JH, Anderson ME, et al. Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates. Nat Biotechnol. 2014;32(10):1059–62.
Chiotellis A, Sladojevich F, Mu L, Muller Herde A, Valverde IE, Tolmachev V, et al. Novel chemoselective 18F-radiolabeling of thiol-containing biomolecules under mild aqueous conditions. Chem Commun (Camb). 2016;52(36):6083–6.
Kalia D, Malekar PV, Parthasarathy M. Exocyclic olefinic maleimides: synthesis and application for stable and thiol-selective bioconjugation. Angew Chem Int Ed Eng. 2016;55(4):1432–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cardinale, J., Giammei, C., Jouini, N., Mindt, T.L. (2019). Bioconjugation Methods for Radiopharmaceutical Chemistry. In: Lewis, J., Windhorst, A., Zeglis, B. (eds) Radiopharmaceutical Chemistry. Springer, Cham. https://doi.org/10.1007/978-3-319-98947-1_25
Download citation
DOI: https://doi.org/10.1007/978-3-319-98947-1_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98946-4
Online ISBN: 978-3-319-98947-1
eBook Packages: MedicineMedicine (R0)